基于代谢谱的中药对慢性心力衰竭作用机制研究
该研究纳入11个独立中心的110例慢性心衰患者,按中医证型分为气虚、气虚血瘀、气虚血瘀水停三组,采用UPLC-TOF/MS检测血浆代谢物并构建诊断模型。模型鉴别心衰组与健康组的敏感度和特异度分别为97.1%和80.6%,并发现9个可能反映中药颗粒疗效的代谢标志物。
要点
- 血浆代谢谱构建的诊断模型对心衰及各证型具有较高敏感度和特异度。
- 6个代谢物可能与心衰相关,各证型分别关联4、7、5个代谢物。
- 9个代谢标志物可能特别反映中药颗粒的疗效。
核心结论
- 血浆代谢谱可用于构建慢性心衰及不同中医证型的诊断模型,并探索中药疗效相关代谢标志物。
研究设计与样本
- 研究纳入来自11个独立中心的110例慢性心衰患者,按中医辨证分为气虚证、气虚血瘀证、气虚血瘀水停证三组,采用UPLC-TOF/MS测定血浆代谢组学谱并进行多变量统计分析。
主要发现
- 约6个代表性代谢物高度可能与慢性心衰相关,气虚证、气虚血瘀证、气虚血瘀水停证分别关联4、7、5个代谢物(VIP > 1,p < 0.05)。
- 诊断模型鉴别慢性心衰组与健康组的敏感度和特异度分别为97.1%和80.6%。
- 诊断模型鉴别气虚证组与健康组的敏感度和特异度分别为97.1%和80.0%。
- 诊断模型鉴别气虚血瘀证组与健康组的敏感度和特异度分别为97.1%和79.5%。
- 诊断模型鉴别气虚血瘀水停证组与健康组的敏感度和特异度分别为97.1%和88.9%。
关键数值与推荐
- 代谢物筛选标准为VIP > 1且p < 0.05。
- 9个代谢标志物(2-花生四烯酰甘油磷酸胆碱、LysoPE 16:0、PS 21:0、LysoPE 20:4、LysoPE 18:0、亚油酸、LysoPE 18:2、4-羟基苯磺酸、LysoPE 22:6)可能特别反映中药颗粒的疗效。
临床怎么用
- 血浆代谢谱诊断模型或可辅助慢性心衰及中医证型的客观辨识。
- 相关代谢标志物可能为评估中药颗粒疗效提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic heart failure (CHF) is a major public health problem in huge population worldwide. The detailed understanding of CHF mechanism is still limited. Zheng (syndrome) is the criterion of diagnosis and therapeutic in Traditional Chinese Medicine (TCM). Syndrome prediction may be a better approach for understanding of CHF mechanism basis and its treatment. The authors studied disturbed metabolic biomarkers to construct a predicting mode to assess the diagnostic value of different syndrome of CHF and explore the Chinese herbal medicine (CHM) efficacy on CHF patients. A cohort of 110 patients from 11 independent centers was studied and all patients were divided into 3 groups according to TCM syndrome differentiation: group of Qi deficiency syndrome, group of Qi deficiency and Blood stasis syndrome, and group of Qi deficiency and Blood stasis and Water retention syndrome. Plasma metabolomic profiles were determined by UPLC-TOF/MS and analyzed by multivariate statistics. About 6 representative metabolites were highly possible to be associated with CHF, 4, 7, and 5 metabolites with Qi deficiency syndrome, Qi deficiency and Blood stasis syndrome, and Qi deficiency and Blood stasis and Water retention syndrome (VIP > 1, p < 0.05). The diagnostic model was further constructed based on the metabolites to diagnose other CHF patients with satisfying sensitivity and specificity (sensitivity and specificity are 97.1 and 80.6% for CHF group vs. NH group; 97.1 and 80.0% for QD group vs. NH group; 97.1 and 79.5% for QB group vs. NH group; 97.1 and 88.9% for QBW group vs. NH group), validating the robustness of plasma metabolic profiling to diagnostic strategy. By comparison of the metabolic profiles, 9 biomarkers, 2-arachidonoylglycerophosphocholine, LysoPE 16:0, PS 21:0, LysoPE 20:4, LysoPE 18:0, linoleic acid, LysoPE 18:2, 4-hydroxybenzenesulfonic acid, and LysoPE 22:6, may be especially for the effect of CHM granules. A predicting model was attempted to construct and predict patient based on the related symptoms of CHF and the potential biomarkers regulated by CHM were explored. This trial was registered with NCT01939236 (https://clinicaltrials.gov/).
引用
- Gao K, Zhao H, Gao J, et al. Mechanism of Chinese Medicine Herbs Effects on Chronic Heart Failure Based on Metabolic Profiling. Front Pharmacol. 2017. PMID: 29213243. doi:10.3389/fphar.2017.00864
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。